Zobrazeno 1 - 10
of 103
pro vyhledávání: '"L Scucchi"'
Autor:
M, Mossa, B, Neri, L, Montesano, S, Salvatori, I, Marafini, L, Scucchi, E, Lolli, R, Massoud, C, Petruzziello, S, Bernardini, E, Calabrese, G, Monteleone, L, Biancone
Publikováno v:
European review for medical and pharmacological sciences. 26(10)
In a prospective study, SARS-CoV-2 IgG seroprevalence was assessed during the second pandemic wave (W2) in a cohort of Inflammatory Bowel Disease (IBD) patients using biologics. The secondary aim was to compare, in the same cohort, the frequency of s
Autor:
S. Onali, D. Pugliese, F.A. Caprioli, A. Orlando, L. Biancone, O.M. Nardone, N. Imperatore, G. Fiorino, M. Cappello, A. Viola, M.B. Principi, C. Bezzio, A. Aratari, S. Carparelli, F. Mancuso, L. Grossi, G. Bodini, D. Ribaldone, G. Mocci, A. Favale, M. Grova, L. Scucchi, S. Segato, W. Fries, F. Castiglione, A. Armuzzi, M.C. Fantini
Publikováno v:
Digestive and Liver Disease. 54:S140-S141
Autor:
S Onali, D Pugliese, F A Caprioli, A Orlando, L Biancone, O M Nardone, N Imperatore, G Fiorino, M Cappello, A Viola, M B Principi, C Bezzio, A Aratari, S Carparelli, S Mazzuoli, F Manguso, L Grossi, G Bodini, D Ribaldone, G Mocci, L Minerba, A Favale, M Grova, L Scucchi, S Segato, W Fries, F Castiglione, A Armuzzi, M C Fantini
Publikováno v:
Journal of Crohn's and Colitis. 16:i542-i543
Background The use of ustekinumab (UST) and vedolizumab (VDZ) as second line therapy in Crohn’s disease (CD) patients failing tumour necrosis factor alpha inhibitors is still debated. The aim of the study was to compare in a large multicentre obser
Autor:
C Bezzio, A D Guarino, G Fiorino, A Armuzzi, D G Ribaldone, F Furfaro, D Pugliese, M Vernero, A Variola, V Gerardi, L Scucchi, C Viganò, F A Caprioli, J Roselli, F Coppini, S Ardizzone, S Onali, F Zingone, M Daperno, C Cortellezzi, S Carparelli, A Soriano, G Manes, S Saibeni
Publikováno v:
Journal of Crohn's and Colitis. 16:i228-i229
Background In the last year, the severe adult respiratory syndrome coronavirus 2 (SARS-CoV-2) epidemic has spread rapidly around the world. The interactions between SARS-CoV-2 and inflammatory bowel disease (IBD) are so far not fully understood. In p
Autor:
C Bezzio, S Costa, A Armuzzi, F Furfaro, S Ardizzone, M Milla, F Bossa, A Orlando, F A Caprioli, F Castiglione, C Viganò, D G Ribaldone, F Zingone, R Monterubbianesi, N Imperatore, S Festa, M Daperno, L Scucchi, A Ferronato, L Pastorelli, P Balestrieri, C Ricci, M Cappello, C Felice, F Coppini, P Alvisi, V Gerardi, A Variola, S Mazzuoli, M V Lenti, S Alessandro, A Buda, F Micheli, V Ciardo, G Casella, A Viscido, G Bodini, G Fiorino, M Vernero, S Saibeni
Publikováno v:
Journal of Crohn's and Colitis. 16:i307-i308
Background Coronavirus disease 2019 (COVID-19), had two pandemic waves in 2020, respectively in April and November. In the general population, the first wave has been characterized by a higher prevalence in Northern Italy and a higher mortality rate
Autor:
L, Scucchi, B, Neri, L, Sarmati, M, Mossa, G, Sena, R, Massoud, C, Petruzziello, M, Musumeci, I, Marafini, E, Calabrese, E, Lolli, S, Bernardini, M, Andreoni, G, Monteleone, L, Biancone
Publikováno v:
European review for medical and pharmacological sciences. 25(5)
Treatments used in Inflammatory Bowel Disease (IBD) have been associated with enhanced risk of viral infections and viral reactivation, however, it remains unclear whether IBD patients have increased risk of Severe Acute Respiratory Syndrome Coronavi
Autor:
L, Scucchi, B, Neri, R, Argirò, D, Nasso, I, Provenzano, S, Potenza, M, Mossa, M, Di Prete, E, Calabrese, C, Petruzziello, A, Mauriello, G, Monteleone, M, Cantonetti, L, Biancone
Publikováno v:
European review for medical and pharmacological sciences. 24(19)
Crohn's Disease (CD) has been associated with non-Hodgkin lymphoma. Follicular Lymphoma (FL) limited to the liver is extremely rare, accounting for 1% to 4.4% of all Primary Hepatic Lymphoma (PHL).In 2018, an 85-years old male patient with post-opera
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.